CONMED Corporation (CNMD) Insider Trading Activity

NYSE$41.8
Market Cap
$1.29B
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
517 of 888
Rank in Industry
71 of 113

CNMD Insider Trading Activity

CNMD Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
0
Sells
$527,273
5
100

Related Transactions

Glaze RichardChief Information Officer
0
$0
1
$10,591
$-10,591
Garner Todd WExecutive Vice President & CFO
0
$0
2
$181,865
$-181,865
Farkas Charlesdirector
0
$0
2
$334,817
$-334,817

About CONMED Corporation

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

Insider Activity of CONMED Corporation

Over the last 12 months, insiders at CONMED Corporation have bought $0 and sold $527,273 worth of CONMED Corporation stock.

On average, over the past 5 years, insiders at CONMED Corporation have bought $544,054 and sold $14.8M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 1,350 shares for transaction amount of $97,322 was made by BRONSON DAVID M (director) on 2024‑05‑13.

List of Insider Buy and Sell Transactions, CONMED Corporation

2025-11-21SaleGlaze RichardChief Information Officer
257
0.0008%
$41.21
$10,591
-3.92%
2025-11-06SaleGarner Todd WExecutive Vice President & CFO
3,500
0.011%
$43.00
$150,500
-6.18%
2025-09-12SaleFarkas Charlesdirector
2,000
0.0065%
$53.52
$107,049
-17.87%
2025-08-07SaleGarner Todd WExecutive Vice President & CFO
598
0.0019%
$52.45
$31,365
-16.89%
2025-05-05SaleFarkas Charlesdirector
4,000
0.0129%
$56.94
$227,768
-14.77%
2025-02-11SaleGlaze RichardChief Information Officer
257
0.0008%
$65.35
$16,796
-21.08%
2024-06-14SalePeters Stanley W IIIPresident AS and AET
4,000
0.0125%
$71.82
$287,280
-5.46%
2024-05-13PurchaseBRONSON DAVID Mdirector
1,350
0.0043%
$72.09
$97,322
-5.75%
2024-05-08PurchaseSchwarzentraub Barbara Jdirector
1,442
0.0047%
$69.26
$99,873
-0.68%
2024-05-06PurchaseAronson Martha Goldbergdirector
2,000
0.0065%
$70.98
$141,960
-2.40%
2024-04-30PurchaseBeyer PatChief Operating Officer
3,000
0.0098%
$68.30
$204,900
+1.76%
2023-12-04SalePeters Stanley W IIIPresident AS and AET
2,300
0.0074%
$109.93
$252,833
-32.96%
2023-11-07SalePeters Stanley W IIIPresident AS and AET
1,200
0.004%
$102.39
$122,874
-24.87%
2023-09-13SalePeters Stanley W IIIPresident AS and AET
2,000
0.0065%
$107.31
$214,629
-25.29%
2023-08-16SaleGarner Todd WExecutive Vice President & CFO
1,355
0.0045%
$112.00
$151,760
-23.56%
2023-06-15SaleHartman Curt RPresident, CEO and Chair
1,000
0.0033%
$136.00
$136,000
-26.80%
2023-06-08SaleFerrell John D.Executive Vice President - HR
1,700
0.0056%
$131.81
$224,077
-23.40%
2023-06-08SalePeters Stanley W IIIVP GM Advanced Surgery
5,000
0.0163%
$131.14
$655,676
-23.40%
2023-06-07SaleCONCANNON BRIANdirector
812
0.0027%
$129.01
$104,756
-21.13%
2023-05-22SalePeters Stanley W IIIVP GM Advanced Surgery
1,500
0.0049%
$120.89
$181,343
-13.18%
Total: 442
*Gray background shows transactions not older than one year

Insider Historical Profitability

6.99%
Farkas Charlesdirector
14859
0.048%
$621,106.20122
+4.46%
Garner Todd WExecutive Vice President & CFO
1836
0.0059%
$76,744.80011
Glaze RichardChief Information Officer
0
0%
$002
CORASANTI JOSEPH JFormer President & CEO
156356
0.5049%
$6.54M038
CORASANTI EUGENE Rdirector
77058
0.2488%
$3.22M053
SHALLISH ROBERT D JREVP, Finance, CFO
53915
0.1741%
$2.25M212
+8.8%
STOTTS JOHN JVP PATIENT CARE
27001
0.0872%
$1.13M01
Cohen Heather LEVP CORP HR
24456
0.079%
$1.02M317
+31.38%
BRONSON DAVID Mdirector
16460
0.0532%
$688,028.0020
<0.0001%
Workman John Ldirector
16035
0.0518%
$670,263.0030
<0.0001%
Jones Gregory RenardEVP-Corporate QA/RA
15367
0.0496%
$642,340.6004
Snyder Mark DEVP Mfg. Ops & Business System
14262
0.0461%
$596,151.6001
Jonas Daniel SSpecial Counsel & Corp Secy
13462
0.0435%
$562,711.60140
<0.0001%
Darling Joseph GEVP, Commercial Operations
12015
0.0388%
$502,227.0006
Beyer PatChief Operating Officer
10807
0.0349%
$451,732.6022
<0.0001%
KENNEDY JOHN JEDGroup Executive Vice President
9855
0.0318%
$411,939.0009
CONCANNON BRIANdirector
9335
0.0301%
$390,203.0004
TRYNISKI MARK Edirector
8296
0.0268%
$346,772.8023
+40.92%
GOLDEN JO ANNdirector
7782
0.0251%
$325,287.60014
SCHWARTZ STUART Jdirector
7400
0.0239%
$309,320.00011
DANIELS BRUCEdirector
5000
0.0161%
$209,000.00015
Kuyper Dirkdirector
5000
0.0161%
$209,000.0015
+37.51%
WILLIAMS FRANK RVICE PRESIDENT
4926
0.0159%
$205,906.8009
MATTHEWS WILLIAMdirector
4500
0.0145%
$188,100.0006
Hartman Curt RPresident, CEO and Chair
4299
0.0139%
$179,698.20410
+10.14%
Ruiz-Caban WilfredoEVP QA, RA and Operations
3951
0.0128%
$165,151.8001
ACEY THOMASSECRETARY & TREASURER
3375
0.0109%
$141,075.00010
Lande Jerome J.
2407
0.0078%
$100,612.6002
JONES ALEXANDERVP CORPORATE SALES
2292
0.0074%
$95,805.6001
Aronson Martha Goldbergdirector
2000
0.0065%
$83,600.0010
<0.0001%
SHAGORY PETER KEVP, STRAT & CORP DEVT
1861
0.006%
$77,789.8009
Folkert NathanVP GM Orthopedics
1600
0.0052%
$66,880.0002
ABRAHAM WILLIAMEVP-Business Development
1486
0.0048%
$62,114.80026
Schwarzentraub Barbara Jdirector
1442
0.0047%
$60,275.6011
<0.0001%
Pelletier Johonna MarieTreasurer and VP, Tax
1317
0.0043%
$55,050.6008
Berge Terence MVP-Corporate Controller
1004
0.0032%
$41,967.20012
Ferrell John D.Executive Vice President - HR
702
0.0023%
$29,343.6001
REMMELL ROBERTdirector
675
0.0022%
$28,215.0001
STARR EUGENEPresident-Electrosurgery
572
0.0018%
$23,909.6002
Peters Stanley W IIIPresident AS and AET
63
0.0002%
$2,633.40018
WOODARD GERALD GPRESIDENT LINVATEC
0
0%
$006
MANDIA STEPHENdirector
1
0%
$22.8106
POMILIO LUKE A
0
0%
$0022
Johnson David AllenVP - Global Operations
0
0%
$005
*Gray background shows insiders who have made transactions during last year

CNMD Institutional Investors: Active Positions

Increased Positions135+40.79%4M+11.63%
Decreased Positions150-45.32%4M-12.62%
New Positions39New2MNew
Sold Out Positions52Sold Out2MSold Out
Total Postitions316-4.53%35M-0.99%

CNMD Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Blackrock, Inc.$188,189.0014.98%4.64M-187,551-3.88%2025-09-30
Vanguard Group Inc$146,314.0011.65%3.61M+62,917+1.77%2025-09-30
Earnest Partners Llc$113,403.009.03%2.8M-31,212-1.1%2025-09-30
Fuller & Thaler Asset Management, Inc.$70,295.005.6%1.73M-5,802-0.33%2025-09-30
Westwood Holdings Group Inc$53,883.004.29%1.33M+92,536+7.48%2025-09-30
Bank Of America Corp /De/$52,736.004.2%1.3M-207,705-13.76%2025-09-30
Dimensional Fund Advisors Lp$52,545.004.18%1.3M+214,126+19.78%2025-09-30
State Street Corp$51,162.004.07%1.26M-30,080-2.33%2025-09-30
Silvercrest Asset Management Group Llc$43,508.003.46%1.07M+221,799+26.03%2025-09-30
Capital Research Global Investors$41,846.003.33%1.03M-643,431-38.39%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.